
About
Mr. Gryska joined our Board of Directors in March 2005. With many years of experience as a senior financial executive at life sciences and biotechnology companies, he brings expertise in financing, global expansion, and other strategic transactions to our board. Mr. Gryska is the chair of our Audit Committee, utilizing his extensive knowledge of accounting principles, financial reporting rules and regulations, tax compliance, and financial reporting processes at publicly traded corporations.
Throughout his career, Mr. Gryska served as a Chief Financial Officer at Incyte Corporation, Celgene Corporation, Scios Inc., and Cardiac Pathways Corporation.
Mr. Gryska holds an M.B.A. from Golden Gate University and a B.A. in Accounting and Finance from Loyola University. He serves as a member of the board of directors of Forte Biosciences, Inc. and Mind Medicine (MindMed) Inc.
Personal Details
Qualifications & Experience
Other directorships (state)
(only entities turnover at least $5m p/a)
| Company | Committee | Position | Date Appointed |
|---|---|---|---|
![]() | Board | Member | 01/01/2023 |
Working history
Committee/s
| Company | Committee | Role | Appointment Date | Resignation Date |
|---|---|---|---|---|
| Seattle Genetics | Board | Member | 01/03/2005 | |
| Seattle Genetics | Audit | Chairperson | 01/03/2005 |
